SENSUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Sensus Healthcare, Inc. on Behalf of Sensus Stockholders and Encourages Investors to Contact the Firm

Core Insights - Sensus Healthcare, Inc. is under investigation for potential violations of federal securities laws and unlawful business practices, prompting a call for affected investors to come forward [2][5]. Financial Performance - For Q2 2025, Sensus reported a GAAP earnings-per-share of -$0.06, missing estimates by $0.09, and revenue of $7.3 million, which is a 20.7% decline year-over-year and $2 million below estimates [3]. - The revenue decline was primarily due to a lower number of units sold to a significant customer, although there was some offset from growth in recurring revenue from Fair Deal Agreements [3]. Stock Market Reaction - Following the financial results announcement, Sensus's stock price dropped by $1.89, or 35.32%, closing at $3.46 per share on August 8, 2025 [4].